Cargando…
PGC1α: an emerging therapeutic target for chemotherapy-induced peripheral neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN)-mediated paresthesias are a common complication in cancer patients undergoing chemotherapy. There are currently no treatments available to prevent or reverse CIPN. Therefore, new therapeutic targets are urgently needed to develop more effective analg...
Autores principales: | Zhai, Mingzhu, Hu, Haibei, Zheng, Yi, Wu, Benqing, Sun, Wuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041632/ https://www.ncbi.nlm.nih.gov/pubmed/36993941 http://dx.doi.org/10.1177/17562864231163361 |
Ejemplares similares
-
Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
por: Li, Yang, et al.
Publicado: (2021) -
PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
por: Corona, Juan Carlos, et al.
Publicado: (2014) -
Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
por: Lee, Gihyun, et al.
Publicado: (2016) -
Quercetin Attenuates Diabetic Peripheral Neuropathy by Correcting Mitochondrial Abnormality via Activation of AMPK/PGC-1α Pathway in vivo and in vitro
por: Zhang, Qian, et al.
Publicado: (2021) -
Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017)